X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Wockhardt with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs TEVA PHARMA (Israel) - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 WOCKHARDT LTD.   TEVA PHARMA
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-16
TEVA PHARMA
Dec-13
WOCKHARDT LTD./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs2,0002,674-   
Low Rs7062,323-   
Sales per share (Unadj.) Rs403.71,534.8-  
Earnings per share (Unadj.) Rs29.595.9-  
Cash flow per share (Unadj.) Rs42.4219.9-  
Dividends per share (Unadj.) Rs083.93-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs323.41,704.9-  
Shares outstanding (eoy) m110.51848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.41.6 205.8%   
Avg P/E ratio x45.926.1 176.2%  
P/CF ratio (eoy) x31.911.4 281.1%  
Price / Book Value ratio x4.21.5 285.4%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m149,5092,118,923 7.1%   
No. of employees `0007.444.9 16.4%   
Total wages/salary Rs m9,4430-   
Avg. sales/employee Rs Th6,048.628,958.0 20.9%   
Avg. wages/employee Rs Th1,280.20-   
Avg. net profit/employee Rs Th441.51,809.0 24.4%   
INCOME DATA
Net Sales Rs m44,6141,301,518 3.4%  
Other income Rs m9700-   
Total revenues Rs m45,5841,301,518 3.5%   
Gross profit Rs m5,038356,421 1.4%  
Depreciation Rs m1,426105,203 1.4%   
Interest Rs m1,01225,564 4.0%   
Profit before tax Rs m3,570225,655 1.6%   
Minority Interest Rs m-651,025 -6.4%   
Prior Period Items Rs m60-   
Extraordinary Inc (Exp) Rs m0-148,130 0.0%   
Tax Rs m255-2,755 -9.2%   
Profit after tax Rs m3,25781,305 4.0%  
Gross profit margin %11.327.4 41.2%  
Effective tax rate %7.1-1.2 -584.6%   
Net profit margin %7.36.2 116.8%  
BALANCE SHEET DATA
Current assets Rs m39,906879,040 4.5%   
Current liabilities Rs m18,423766,598 2.4%   
Net working cap to sales %48.28.6 557.3%  
Current ratio x2.21.1 188.9%  
Inventory Days Days9091 99.3%  
Debtors Days Days9896 102.4%  
Net fixed assets Rs m35,832425,104 8.4%   
Share capital Rs m5533,204 17.2%   
"Free" reserves Rs m30,3700-   
Net worth Rs m35,7391,445,740 2.5%   
Long term debt Rs m16,542665,495 2.5%   
Total assets Rs m79,5222,974,386 2.7%  
Interest coverage x4.59.8 46.1%   
Debt to equity ratio x0.50.5 100.6%  
Sales to assets ratio x0.60.4 128.2%   
Return on assets %5.43.6 149.4%  
Return on equity %9.15.6 162.0%  
Return on capital %8.74.9 175.5%  
Exports to sales %11.60-   
Imports to sales %4.50-   
Net fx Rs m4,7110-   
CASH FLOW
From Operations Rs m716207,395 0.3%  
From Investments Rs m-8,182-73,488 11.1%  
From Financial Activity Rs m2,543-248,784 -1.0%  
Net Cashflow Rs m-4,923-114,878 4.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.07 Rs / USD

Compare WOCKHARDT LTD. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare WOCKHARDT LTD. With: ALKEM LABORATORIES  UNICHEM LAB  PLETHICO PHARMA  AJANTA PHARMA  DISHMAN PHARMA  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Aug 23, 2017 (Close)

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS